Literature DB >> 30038351

Low mean post-transplantation tacrolimus levels in weeks 2-3 correlate with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation from related and unrelated donors.

Patrick A Hagen1, William Adams2, Scott Smith3, Stephanie Tsai4, Patrick Stiff5.   

Abstract

Entities:  

Year:  2018        PMID： 30038351     DOI： 10.1038/s41409-018-0267-5

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

1.  Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients.

Authors:  Kathryn T Maples; Molly Maloy; Sean Devlin; Andrew Lin; Lauren DeRespiris; Meagan Griffin; Carmen Lau; Anthony J Proli; Genovefa A Papanicolaou; Susan K Seo; Juliet N Barker; Miguel-Angel Perales; Sergio A Giralt; Valkal Bhatt
Journal:  Bone Marrow Transplant       Date:  2020-01-14       Impact factor: 5.483

2.  Evaluating risk factors for acute graft versus host disease in pediatric hematopoietic stem cell transplant patients receiving tacrolimus.

Authors:  Michael Phan; Rishikesh Chavan; Richard Beuttler; Nicole Benipayo; Grace Magedman; David Buchbinder; Daniel Tomaszewski; Sun Yang
Journal:  Clin Transl Sci       Date:  2021-04-08       Impact factor: 4.689

3.  Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients.

Authors:  Jing Zhu; Olivia Campagne; Chad D Torrice; Gabrielle Flynn; Jordan A Miller; Tejendra Patel; Oscar Suzuki; Jonathan R Ptachcinski; Paul M Armistead; Tim Wiltshire; Donald E Mager; Daniel L Weiner; Daniel J Crona
Journal:  Clin Transl Sci       Date:  2021-01-27       Impact factor: 4.689
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.